Mg Composite | List of Frontiers open access articles

Original Research

Published on 09 Sep 2022

Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients

in Neuromuscular Disorders and Peripheral Neuropathies

Xin Huang
Hao Ran
Yingkai Li
Qian Ma
Changyi Ou
Li Qiu
Huiyu Feng
Weibin Liu

Frontiers in Neurology

doi 10.3389/fneur.2022.961628

7,157 views
4 citations

Original Research

Published on 25 Aug 2020

Pharmacodynamic Properties of Subcutaneous Immunoglobulin in Myasthenia Gravis: Sub-analyses From an Open-Label Trial

in Neuromuscular Disorders and Peripheral Neuropathies

Brendan N. Putko
Grayson Beecher
Zaeem A. Siddiqi

Frontiers in Neurology

doi 10.3389/fneur.2020.00921

3,408 views
3 citations

Original Research

Published on 21 Jun 2022

LncRNA LINC00680 Acts as a Competing Endogenous RNA and Is Associated With the Severity of Myasthennia Gravis

in Neuromuscular Disorders and Peripheral Neuropathies

Li Liu
Huixue Zhang
Xiaoyu Lu
Lifang Li
Tianfeng Wang
Shuang Li
Xu Wang
Si Xu
Lei Li
Qian Li

Frontiers in Neurology

doi 10.3389/fneur.2022.833062

2,989 views
2 citations

Original Research

Published on 22 Apr 2024

B-cell immune dysregulation with low soluble CD22 levels in refractory seronegative myasthenia gravis

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Yuumi Okuzono
Shuuichi Miyakawa
Tatsuo Itou
Masaki Sagara
Masashi Iwata
Kei Ishizuchi
Koji Sekiguchi
Haruhiko Motegi
Munenori Oyama
Dnyaneshwar Warude

Frontiers in Immunology

doi 10.3389/fimmu.2024.1382320

8,825 views
10 citations

Original Research

Published on 08 Apr 2024

Effect of Mg incorporation on the properties of PCL/Mg composites for potential tissue engineering applications

in Polymeric and Composite Materials

Sumama Nuthana Kalva
Fawad Ali
Kripa Subhadra Keyan
Omar M. Khan
Mujaheed Pasha
Carlos A. Velasquez
Muammer Koç

Frontiers in Materials

doi 10.3389/fmats.2024.1294811

3,223 views
9 citations

Original Research

Published on 23 Dec 2024

Cutoffs on severity metrics for minimal manifestations or better status in patients with generalized myasthenia gravis

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Genya Watanabe
Yoshiki Takai
Yuriko Nagane
Tomoya Kubota
Manato Yasuda
Hiroyuki Akamine
Yosuke Onishi
Akiyuki Uzawa
Naoki Kawaguchi
Masayuki Masuda

Frontiers in Immunology

doi 10.3389/fimmu.2024.1502721

4,961 views
8 citations

Articles

Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients

Pharmacodynamic Properties of Subcutaneous Immunoglobulin in Myasthenia Gravis: Sub-analyses From an Open-Label Trial

LncRNA LINC00680 Acts as a Competing Endogenous RNA and Is Associated With the Severity of Myasthennia Gravis

B-cell immune dysregulation with low soluble CD22 levels in refractory seronegative myasthenia gravis

Effect of Mg incorporation on the properties of PCL/Mg composites for potential tissue engineering applications

Cutoffs on severity metrics for minimal manifestations or better status in patients with generalized myasthenia gravis